EntrezGene:56834

Symbol:	GPR137
Description:	G protein-coupled receptor 137
Synonyms:	C11orf4, GPR137A, TM7SF1L1
Species:	Human (Homo sapiens)
Xrefs:	ExpandEntrezGene:56834 HGNC:24300 Ensembl:ENSG00000173264 HPRD:12600 Vega:OTTHUMG00000167817
Associated motifs:	NA
Transcripton Factor?:	No

TSS regions

---

Copy Excel CSV PDF

Show 102550All entries

Search:

Hg19::chr11:64037688..64037776,+	p3@GPR137
Hg19::chr11:64052238..64052249,+	p38@GPR137
Hg19::chr11:64052266..64052288,+	p5@GPR137
Hg19::chr11:64052294..64052347,+	p1@GPR137
Hg19::chr11:64052454..64052481,+	p16@GPR137
Hg19::chr11:64052649..64052689,+	p6@GPR137
Hg19::chr11:64052692..64052747,+	p4@GPR137
Hg19::chr11:64052944..64052986,+	p7@GPR137
Hg19::chr11:64052990..64053004,+	p11@GPR137
Hg19::chr11:64053005..64053049,+	p9@GPR137
TSS peak ID	Short_description

Showing 1 to 10 of 14 entries

Previous12Next

View on UCSC genome browser

---

Mouse over to see Genome browser image, Click image to go to Genome browser

TSS expression

---

Copy Excel CSV PDF

Search:

Sample	p1@GPR137	p2@GPR137	p3@GPR137	p4@GPR137	p5@GPR137

Sample	p1@GPR137	p2@GPR137	p3@GPR137	p4@GPR137	p5@GPR137
Placental Epithelial Cells, donor1.CNhs11079.11278-116H9	56.38	5.46	13.64	6.37	5.15
Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1	35.47	9.25	7.71	23.13	1.54
pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5	31.43	3.40	1.05	2.62	1.31
Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7	28.61	28.61	21.46	39.34	0.00
testis, adult, pool2.CNhs12998.10096-102C6	27.60	30.01	4.82	3.22	15.01
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4	27.47	11.16	17.17	4.29	2.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1	27.36	3.61	12.33	5.26	2.10
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1	25.29	13.43	15.80	3.95	1.58
Osteoblast - differentiated, donor2.CNhs11980.11353-117H3	25.01	11.37	0.00	13.64	2.27
Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4	23.90	4.60	9.19	1.84	0.92
Melanocyte - light, donor1.CNhs11303.11274-116H5	22.92	15.66	9.55	4.58	4.58
placenta, adult, pool1.CNhs10627.10021-101D3	22.80	7.36	17.65	3.55	2.57
Placental Epithelial Cells, donor3.CNhs12037.11427-118G5	22.68	8.16	5.14	3.63	0.60
Melanocyte - light, donor2.CNhs11383.11351-117H1	22.27	28.13	14.07	4.69	1.17
Osteoblast - differentiated, donor3.CNhs12035.11425-118G3	20.69	4.14	1.03	1.03	1.03
Melanocyte - light, donor3.CNhs12033.11423-118G1	20.53	8.55	6.84	1.71	5.13
Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7	19.93	3.07	13.80	3.07	3.07
papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5	19.49	4.75	0.98	2.78	0.66
Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8	18.98	2.11	2.71	1.51	1.51
Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6	18.84	4.19	3.49	7.68	1.40
Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4	18.81	7.05	1.83	3.40	1.57
testis, adult, pool1.CNhs10632.10026-101D8	18.79	37.28	2.42	4.62	13.11
embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9	18.66	4.04	6.12	0.41	1.87
chorionic membrane cells, donor3.CNhs12380.12240-129G8	18.12	2.67	3.20	1.07	1.60
Pericytes, donor1.CNhs11317.11491-119E6	18.01	20.56	5.48	2.94	4.90
choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9	17.68	3.68	2.60	0.45	0.63
Renal Epithelial Cells, donor2.CNhs12088.11597-120H4	17.54	4.38	0.00	1.46	0.00
Renal Epithelial Cells, donor1.CNhs11332.11517-119H5	16.47	8.63	7.84	3.14	0.00
choriocarcinoma cell line:SCH.CNhs11875.10785-110H2	15.97	2.39	6.08	0.43	0.76
chorionic membrane cells, donor1.CNhs12504.12238-129G6	15.95	4.15	7.66	2.23	0.64
mesothelioma cell line:Mero-25.CNhs13066.10850-111F4	15.92	2.61	8.61	2.61	0.26
Pericytes, donor2.CNhs12079.11571-120E5	15.44	14.76	3.43	1.37	6.52
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8	15.37	2.91	2.08	0.00	1.25
oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2	15.21	11.09	2.55	0.79	0.98
salivary acinar cells, donor2.CNhs12811.11772-123I8	15.02	4.44	3.76	2.56	1.37
Placental Epithelial Cells, donor2.CNhs11386.11355-117H5	14.98	11.65	6.66	1.66	4.99
Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3	14.79	4.07	4.07	2.59	1.11
alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6	14.78	3.41	0.00	1.42	1.42
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6	14.54	4.90	16.01	1.17	2.12
mesothelioma cell line:No36.CNhs13074.10857-111G2	14.51	7.60	2.42	1.73	0.69
lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8	14.37	3.59	2.39	1.20	2.39
CD19+ B Cells, donor1.CNhs12343.11544-120B5	14.23	0.00	1.14	10.82	1.14
Wilms' tumor cell line:G-401.CNhs11892.10809-111A8	14.10	4.17	1.92	1.39	1.18
Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6	13.99	6.18	3.58	0.33	2.28
brain, adult, donor1.CNhs11796.10084-102B3	13.57	23.26	4.85	2.91	4.85
anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4	13.51	6.97	6.54	0.00	0.63
colon, adult, donor1.CNhs11794.10082-102B1	12.94	2.99	11.94	2.99	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4	12.79	5.09	3.16	0.55	0.69
Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1	12.74	4.02	1.34	0.67	0.67
fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9	12.72	6.36	4.17	1.79	1.39
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5	12.62	5.30	7.59	0.71	1.94
adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4	12.54	2.81	2.81	1.50	0.75
Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5	12.49	6.45	1.21	12.89	0.81
Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9	12.27	7.22	2.89	5.78	1.44
Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9	12.25	3.31	3.31	1.29	0.83
Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1	12.25	11.55	4.20	1.75	0.35
CD19+ B Cells, donor3.CNhs12354.11705-123B4	12.23	0.76	0.76	8.41	1.91
Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1	12.20	4.88	3.17	12.20	2.68
nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3	12.17	3.50	2.80	0.42	1.40
CD4+ T Cells, donor3.CNhs11998.11382-118B5	12.13	0.41	0.00	2.88	0.62
Adipocyte - omental, donor2.CNhs12067.11474-119C7	12.01	9.01	4.00	5.00	2.00
mesothelioma cell line:Mero-82.CNhs13069.10853-111F7	11.99	4.65	2.69	4.89	0.73
Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1	11.98	6.53	8.71	5.44	1.09
Neutrophils, donor2.CNhs11959.11314-117C9	11.97	0.00	2.99	0.00	2.99
Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3	11.80	4.15	1.09	1.53	0.87
Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4	11.77	3.95	14.50	3.77	3.67
Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2	11.61	5.80	2.11	2.11	0.26
substantia nigra, adult, donor10252.CNhs12318.10158-103A5	11.61	7.74	11.18	0.72	1.72
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6	11.57	2.78	5.56	20.83	1.39
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9	11.49	4.59	1.15	4.59	1.15
Natural Killer Cells, donor2.CNhs11957.11311-117C6	11.43	1.94	1.08	4.74	0.86
Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4	11.33	4.61	3.36	5.45	1.68
Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9	11.28	5.78	3.30	1.10	0.00
Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8	11.22	7.01	5.61	8.41	2.80
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5	11.13	5.13	12.77	1.74	1.35
Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1	11.00	15.98	4.39	1.77	7.33
Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2	10.95	9.39	1.56	1.56	1.56
Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4	10.75	1.85	2.60	1.85	0.37
hepatoma cell line:Li-7.CNhs11271.10484-107A7	10.73	4.43	2.85	0.89	0.98
liver, adult, pool1.CNhs10624.10018-101C9	10.70	4.10	1.47	1.47	1.61
Neural stem cells, donor1.CNhs11063.11275-116H6	10.67	9.91	3.05	0.76	0.76
Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3	10.59	11.55	8.66	0.96	0.96
Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5	10.56	6.19	2.91	2.19	1.09
small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8	10.53	13.10	1.64	0.70	4.44
Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2	10.51	3.87	6.04	0.73	0.48
SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5	10.41	3.50	15.66	2.58	3.30
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8	10.34	4.30	5.81	0.46	0.81
mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2	10.31	3.72	4.05	3.38	1.52
merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6	10.30	20.61	3.75	0.47	4.22
Chondrocyte - re diff, donor3.CNhs12021.11411-118E7	10.22	2.92	4.38	0.49	0.49
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6	10.20	2.40	3.00	0.60	0.90
Urothelial Cells, donor3.CNhs12122.11681-122H7	10.20	5.32	1.77	2.66	0.00
liposarcoma cell line:SW 872.CNhs11851.10726-110A6	10.20	8.84	0.68	2.72	0.79
adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9	10.19	15.29	6.07	3.03	1.82
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7	10.16	6.22	4.15	0.41	0.83
Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4	10.11	12.58	2.96	4.93	2.47
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6	10.09	5.05	5.55	0.76	0.50
H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6	10.00	4.39	4.15	0.12	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5	9.97	3.70	3.38	0.32	0.80
carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3	9.90	8.85	2.78	0.69	1.22
fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2	9.87	3.70	1.51	0.96	0.27
Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7	9.86	9.86	6.68	2.86	1.59
mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9	9.84	12.15	3.47	4.63	0.58
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7	9.77	5.67	14.29	1.56	1.56
serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9	9.73	2.46	3.24	0.34	0.89
oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4	9.70	3.12	1.50	4.04	0.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5	9.67	3.45	5.04	0.40	0.93
Chondrocyte - de diff, donor2.CNhs11372.11338-117F6	9.53	9.02	3.01	2.51	1.50
mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6	9.38	9.61	1.83	2.29	1.37
CD8+ T Cells, donor2.CNhs11956.11307-117C2	9.36	1.60	1.34	4.55	2.14
mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1	9.36	7.60	4.06	3.18	0.71
Osteoblast - differentiated, donor1.CNhs11311.11276-116H7	9.33	7.52	0.90	2.71	0.60
mesothelioma cell line:Mero-83.CNhs13070.10854-111F8	9.31	7.16	2.33	2.69	1.25
liver, fetal, pool1.CNhs11798.10086-102B5	9.28	2.65	2.65	9.28	1.33
small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4	9.28	8.32	4.28	0.59	4.52
chorionic membrane cells, donor2.CNhs12506.12239-129G7	9.25	5.68	3.30	2.02	1.19
Natural Killer Cells, donor3.CNhs12001.11387-118C1	9.24	1.41	1.93	7.19	1.28
serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9	9.16	4.81	2.52	4.35	0.92
Sebocyte, donor2.CNhs11951.11301-117B5	9.10	3.25	2.60	0.65	0.00
Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5	9.09	1.49	1.49	1.82	0.50
keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8	9.06	2.68	2.35	0.34	0.34
Neurons, donor2.CNhs12726.11574-120E8	9.05	10.22	2.01	0.50	3.18
Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6	9.04	11.30	4.52	2.26	2.26
Renal Mesangial Cells, donor3.CNhs12121.11679-122H5	9.03	9.53	3.51	2.01	4.01
salivary acinar cells, donor3.CNhs12812.11773-123I9	8.99	6.91	4.15	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9	8.96	0.43	9.81	3.41	0.00
cerebellum, adult, pool1.CNhs11795.10083-102B2	8.87	18.92	4.14	0.30	3.55
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6	8.85	3.46	3.46	1.15	0.77
mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3	8.83	5.05	1.26	1.26	2.52
Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2	8.82	7.35	1.47	2.94	1.47
Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9	8.78	2.51	7.31	2.09	0.84
Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7	8.78	11.05	4.39	1.36	0.91
ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2	8.74	10.68	2.19	1.70	0.73
Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2	8.73	3.13	2.24	0.90	0.67
Meningeal Cells, donor2.CNhs12080.11573-120E7	8.72	10.03	4.80	2.18	1.74
ductus deferens, adult.CNhs12846.10196-103E7	8.68	4.74	11.05	1.97	1.58
CD4+ T Cells, donor2.CNhs11955.11306-117C1	8.65	0.00	1.97	5.90	0.79
myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9	8.65	11.78	4.79	1.84	1.66
vagina, adult.CNhs12854.10204-103F6	8.65	3.99	19.97	1.33	2.00
Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5	8.57	7.14	3.47	0.82	1.63
Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4	8.57	5.41	1.35	0.45	0.45
transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4	8.55	7.57	1.79	1.14	1.38
bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8	8.51	6.62	3.55	2.13	0.95
cerebellum, adult, donor10252.CNhs12323.10166-103B4	8.51	12.50	21.78	0.44	2.65
Adipocyte - omental, donor3.CNhs12068.11475-119C8	8.49	5.81	1.79	2.68	2.68
Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2	8.46	2.11	2.11	1.15	0.58
Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5	8.45	7.40	7.40	0.00	0.00
Urothelial Cells, donor2.CNhs12091.11600-120H7	8.42	0.00	0.00	1.68	1.68
astrocytoma cell line:TM-31.CNhs10742.10425-106D2	8.39	12.48	1.94	0.41	2.86
osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2	8.39	8.39	0.38	0.38	0.76
eye, fetal, donor1.CNhs11762.10054-101G9	8.36	9.04	3.84	1.36	1.81
Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2	8.31	8.31	0.00	3.32	0.00
Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5	8.26	5.86	2.66	1.86	1.33
teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6	8.24	5.70	4.69	0.25	0.89
kidney, adult, pool1.CNhs10622.10017-101C8	8.20	6.86	6.38	2.76	1.89
Renal Mesangial Cells, donor1.CNhs11333.11518-119H6	8.13	5.96	4.34	0.81	0.81
normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3	8.11	8.11	0.71	0.71	3.88
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4	8.10	3.38	1.60	0.62	1.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9	8.03	4.30	3.73	1.43	0.86
Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6	8.00	6.28	3.08	0.49	1.23
neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9	7.98	5.77	4.41	1.36	1.53
CD8+ T Cells, donor3.CNhs11999.11383-118B6	7.97	1.74	0.58	5.36	1.01
Chondrocyte - de diff, donor1.CNhs11923.11261-116G1	7.95	5.42	0.72	1.45	0.00
Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4	7.93	7.93	4.76	4.76	1.59
Mallassez-derived cells, donor2.CNhs13550.11929-125I3	7.90	2.35	1.85	1.34	1.01
mesothelioma cell line:Mero-95.CNhs13073.10856-111G1	7.89	7.24	3.51	2.41	0.88
Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8	7.87	3.37	13.49	3.37	1.12
Preadipocyte - breast, donor2.CNhs11971.11328-117E5	7.86	6.74	3.37	1.68	1.68
gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2	7.79	12.19	3.40	3.80	0.80
Eosinophils, donor3.CNhs12549.12246-129H5	7.76	3.88	3.88	7.76	3.88
Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1	7.76	5.98	3.07	0.97	0.81
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1	7.75	2.36	8.02	0.74	1.55
Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7	7.72	7.08	6.43	3.86	0.64
mesothelioma cell line:Mero-84.CNhs13072.10855-111F9	7.72	5.25	4.63	4.32	0.31
spinal cord, adult, donor10252.CNhs12227.10159-103A6	7.72	5.64	13.07	0.30	2.38
Melanocyte - dark, donor3.CNhs12570.11663-122F7	7.68	8.38	3.24	1.65	0.89
Preadipocyte - omental, donor2.CNhs11902.11329-117E6	7.68	6.14	1.54	3.07	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9	7.66	2.92	4.01	0.36	1.09
Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6	7.64	2.73	2.18	4.64	0.27
mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6	7.64	4.40	2.08	3.94	0.46
renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3	7.64	0.96	8.60	2.87	1.43
CD19+ B Cells, donor2.CNhs12352.11624-122B4	7.63	1.17	0.00	8.81	0.00
cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5	7.63	7.52	0.91	1.37	0.80
mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2	7.62	5.71	0.38	2.28	0.00
seminal vesicle, adult.CNhs12851.10201-103F3	7.62	2.96	11.01	1.27	2.54
mesothelioma cell line:ONE58.CNhs13075.10858-111G3	7.60	7.90	2.13	2.73	0.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9	7.58	2.81	3.37	0.00	0.28
occipital lobe, fetal, donor1.CNhs11784.10073-102A1	7.56	6.05	0.76	0.25	2.52
mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5	7.54	8.52	2.62	0.98	0.66
Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5	7.52	10.97	2.51	0.94	1.57
glioma cell line:GI-1.CNhs10731.10413-106B8	7.51	8.09	0.58	0.87	0.87
thyroid, adult, pool1.CNhs10634.10028-101E1	7.51	4.96	5.92	2.16	4.46
Basophils, donor1.CNhs12546.12241-129G9	7.47	1.18	0.39	2.36	0.39
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2	7.44	9.30	0.46	0.93	0.46
rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4	7.44	4.30	4.07	0.70	0.81
Preadipocyte - omental, donor1.CNhs11065.11468-119C1	7.43	7.82	2.69	2.95	1.28
postcentral gyrus, adult, pool1.CNhs10638.10032-101E5	7.43	27.43	1.38	1.64	2.96
temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9	7.42	8.29	0.87	0.87	3.49
Prostate Stromal Cells, donor3.CNhs12015.11405-118E1	7.34	8.52	1.57	6.43	1.05
Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3	7.33	2.56	3.11	0.73	1.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5	7.32	8.78	0.00	3.42	0.00
Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4	7.32	9.49	1.09	2.17	0.54
Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4	7.30	3.50	3.80	0.72	1.54
Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8	7.29	5.05	1.68	1.68	0.56
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4	7.28	7.55	2.43	0.54	0.81
embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2	7.28	4.63	1.32	2.65	0.99
hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7	7.28	3.05	1.86	1.78	0.25
breast, adult, donor1.CNhs11792.10080-102A8	7.25	1.45	7.25	3.62	5.07
small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4	7.25	8.60	4.68	2.42	1.06
Preadipocyte - omental, donor3.CNhs12013.11403-118D8	7.24	10.94	3.70	2.25	1.13
Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7	7.22	4.59	2.30	0.66	0.98
gastric cancer cell line:AZ521.CNhs11286.10549-107H9	7.22	5.61	1.95	0.92	1.49
Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2	7.21	5.31	1.52	0.76	0.38
colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9	7.21	6.36	1.55	0.14	0.71
peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4	7.21	4.22	8.97	0.70	0.88
mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6	7.20	10.35	2.25	3.15	1.35
oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1	7.20	6.25	4.36	0.35	1.89
Keratocytes, donor1.CNhs11337.11527-119I6	7.17	8.15	4.56	0.00	0.65
breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5	7.17	14.34	2.10	0.44	1.22
mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8	7.17	2.56	6.15	1.02	0.51
Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6	7.15	2.51	0.58	2.13	0.97
Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3	7.10	7.30	2.43	1.22	0.61
Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9	7.06	6.84	4.74	2.21	0.88
Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6	7.02	4.21	6.51	1.15	0.26
medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6	7.01	15.52	10.52	0.88	2.75
medulla oblongata, adult, donor10252.CNhs12315.10155-103A2	6.99	8.65	10.98	0.33	3.22
Adipocyte - perirenal, donor1.CNhs12069.11476-119C9	6.98	11.34	2.62	1.74	2.62
Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3	6.98	1.81	2.58	2.84	0.78
Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4	6.98	3.49	1.31	2.18	1.31
Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1	6.97	3.71	1.39	5.11	0.93
Mesothelial Cells, donor2.CNhs12197.12156-128G5	6.97	11.33	1.74	1.74	0.00
Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1	6.97	3.40	2.55	3.23	0.85
Olfactory epithelial cells, donor2.CNhs13817.11934-125I8	6.96	4.46	0.71	2.50	1.78
skeletal muscle, fetal, donor1.CNhs11776.10066-101I3	6.96	4.64	3.48	2.32	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1	6.95	5.27	2.40	1.20	0.96
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3	6.93	8.81	5.04	1.26	0.94
glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3	6.93	18.35	1.36	2.31	1.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8	6.93	2.36	6.54	1.02	1.42
Synoviocyte, donor3.CNhs12050.11440-118H9	6.92	5.60	1.32	6.92	0.99
Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7	6.91	5.53	9.67	2.76	0.00
Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9	6.91	6.07	3.37	1.85	1.35
Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3	6.91	6.61	2.40	1.80	0.90
Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9	6.90	6.13	4.98	0.77	0.77
Fibroblast - skin normal, donor1.CNhs11351.11553-120C5	6.89	7.07	1.86	1.30	0.74
Urothelial Cells, donor1.CNhs11334.11520-119H8	6.89	2.15	1.72	1.29	0.00
Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3	6.88	1.72	6.88	1.72	0.86
nasal epithelial cells, donor2.CNhs12574.12227-129F4	6.84	1.87	0.00	3.11	0.62
Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2	6.82	2.27	1.14	6.82	2.27
parietal lobe, adult, donor10252.CNhs12317.10157-103A4	6.82	13.43	7.85	0.41	3.10
mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7	6.81	7.11	1.06	2.27	1.36
mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5	6.79	8.05	1.26	1.51	0.50
Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8	6.78	2.83	5.09	1.70	0.57
Olfactory epithelial cells, donor3.CNhs13818.11935-125I9	6.78	7.41	0.63	2.84	0.63
rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9	6.78	7.13	9.21	0.35	0.52
Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7	6.74	4.04	2.56	1.21	1.35
locus coeruleus, adult, donor10252.CNhs12322.10165-103B3	6.74	12.96	11.11	0.26	2.38
prostate cancer cell line:DU145.CNhs11260.10490-107B4	6.74	4.49	2.72	1.77	1.42
Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9	6.72	7.63	1.29	1.16	1.42
occipital pole, adult, pool1.CNhs10643.10036-101E9	6.71	31.81	2.01	1.45	2.84
squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4	6.71	9.53	4.23	3.18	0.71
choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6	6.69	3.23	4.61	0.00	0.69
renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6	6.69	4.75	3.89	4.97	1.94
amniotic membrane cells, donor1.CNhs12502.12235-129G3	6.68	2.63	5.49	1.19	1.43
brain, adult, pool1.CNhs10617.10012-101C3	6.68	19.48	1.67	1.02	2.32
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5	6.67	4.32	1.37	0.78	0.59
mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9	6.65	5.77	1.77	1.03	0.44
Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3	6.64	2.85	9.49	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9	6.64	2.21	2.95	4.43	0.74
Osteoblast, donor2.CNhs11385.11354-117H4	6.64	3.32	2.66	0.66	0.00
medulla oblongata, adult, pool1.CNhs10645.10038-101F2	6.64	15.96	4.78	0.56	2.30
Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2	6.62	12.68	4.41	1.65	0.55
kidney, fetal, pool1.CNhs10652.10045-101F9	6.61	5.19	6.56	1.26	2.10
neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4	6.61	14.00	2.20	0.31	1.73
Eosinophils, donor2.CNhs12548.12245-129H4	6.59	3.95	9.22	6.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6	6.59	5.95	3.39	0.09	1.56
retina, adult, pool1.CNhs10636.10030-101E3	6.58	11.36	6.29	1.14	2.07
Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2	6.57	13.72	2.29	0.86	0.00
globus pallidus, adult, donor10252.CNhs12319.10161-103A8	6.57	7.26	14.38	0.68	1.23
osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9	6.56	4.18	0.60	0.00	0.40
Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3	6.55	2.54	1.39	1.00	1.00
carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1	6.55	4.14	3.10	0.00	2.07
occipital cortex, adult, donor10252.CNhs12320.10163-103B1	6.54	10.38	11.33	1.12	1.44
acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5	6.53	2.06	2.75	0.34	1.03
Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9	6.51	16.82	3.26	1.63	0.54
Natural Killer Cells, donor1.CNhs10859.11230-116C6	6.50	1.18	1.38	2.76	0.39
Adipocyte - omental, donor1.CNhs11054.11473-119C6	6.48	6.48	4.09	2.68	2.11
amniotic membrane cells, donor3.CNhs12379.12237-129G5	6.45	2.76	2.15	0.92	1.23
bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1	6.44	1.07	5.91	0.36	1.25
Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7	6.43	11.87	3.21	3.46	0.74
Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2	6.41	5.93	4.03	1.90	0.47
Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4	6.40	3.94	5.66	0.86	0.61
parietal lobe, adult, pool1.CNhs10641.10034-101E7	6.40	24.99	3.68	1.08	2.47
Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3	6.37	7.28	7.28	1.82	0.00
Myoblast, donor2.CNhs11965.11322-117D8	6.37	5.14	2.47	1.03	0.62
Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2	6.37	2.33	2.33	1.52	0.91
prostate cancer cell line:PC-3.CNhs11243.10439-106E7	6.34	7.23	2.67	0.89	1.33
Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1	6.33	5.86	4.45	0.70	0.94
Synoviocyte, donor2.CNhs11992.11368-117I9	6.33	6.12	0.84	3.80	0.63
Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4	6.32	10.11	1.90	2.53	1.26
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9	6.28	4.31	3.77	1.08	0.90
Lens Epithelial Cells, donor2.CNhs12568.11609-120I7	6.26	11.94	2.67	1.74	0.81
Keratocytes, donor2.CNhs12095.11607-120I5	6.24	5.20	3.12	0.00	0.00
middle temporal gyrus, donor10252.CNhs12316.10156-103A3	6.22	11.75	11.75	0.55	2.07
lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3	6.21	1.66	4.56	2.49	0.83
thalamus, adult, donor10252.CNhs12314.10154-103A1	6.21	8.58	14.27	0.52	2.48
caudate nucleus - adult, donor10196.CNhs13802.10177-103C6	6.20	7.97	6.20	0.89	1.77
Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3	6.19	5.41	3.77	0.58	0.97
Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3	6.18	1.77	3.09	0.44	1.32
Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4	6.18	2.87	0.90	1.16	0.54
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9	6.18	2.47	6.92	0.49	1.07
glioblastoma cell line:A172.CNhs11185.10444-106F3	6.17	16.32	0.84	1.67	1.26
Meningeal Cells, donor3.CNhs12731.11654-122E7	6.16	2.27	1.98	0.88	0.95
Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8	6.15	5.68	4.73	2.01	1.06
testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6	6.15	0.27	3.74	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2	6.13	1.02	0.00	0.00	3.07
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2	6.09	1.71	1.33	12.56	0.95
Chondrocyte - de diff, donor3.CNhs12020.11410-118E6	6.08	7.24	1.59	1.16	1.01
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3	6.04	5.68	3.91	1.07	1.07
testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3	6.02	2.24	0.51	0.31	0.71
heart, adult, diseased, donor1.CNhs11758.10051-101G6	6.01	4.29	1.29	1.29	0.43
brain, fetal, pool1.CNhs11797.10085-102B4	5.99	5.99	2.00	0.00	7.98
breast carcinoma cell line:MCF7.CNhs11943.10482-107A5	5.99	3.91	3.65	1.56	0.52
trachea, fetal, donor1.CNhs11766.10058-101H4	5.99	1.66	3.99	0.00	0.67
CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9	5.97	0.20	1.19	0.99	1.59
Olfactory epithelial cells, donor4.CNhs13819.11936-126A1	5.97	6.56	1.29	1.76	1.52
Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7	5.97	5.97	3.98	1.99	0.66
Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2	5.94	17.81	5.94	0.00	1.48
Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8	5.92	6.20	3.66	0.85	0.85
Renal Epithelial Cells, donor3.CNhs12732.11678-122H4	5.91	3.27	1.48	1.37	1.06
melanoma cell line:COLO 679.CNhs11281.10514-107E1	5.91	4.55	1.67	2.43	0.61
Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2	5.89	3.15	2.19	0.00	0.96
Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6	5.88	0.37	1.84	0.37	1.10
Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1	5.88	8.93	4.36	2.18	0.87
Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3	5.86	2.04	0.76	1.53	0.76
corpus callosum, adult, pool1.CNhs10649.10042-101F6	5.86	8.56	7.75	1.28	3.37
Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5	5.85	7.80	3.90	2.93	0.49
Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8	5.83	1.81	1.31	1.41	0.30
Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3	5.82	3.73	1.76	1.43	1.10
Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7	5.82	1.08	1.08	3.45	0.65
endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7	5.82	6.24	0.97	1.25	1.53
duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8	5.82	0.53	5.82	1.06	1.59
Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8	5.81	3.21	2.21	1.00	0.40
salivary acinar cells, donor1.CNhs12810.11771-123I7	5.80	4.56	4.35	1.04	0.62
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1	5.77	1.73	3.18	14.73	1.01
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8	5.76	1.15	1.34	0.38	0.58
Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2	5.75	13.65	3.59	10.06	2.16
medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3	5.75	4.87	4.50	1.62	0.50
Mesothelial Cells, donor1.CNhs10850.11247-116E5	5.73	7.23	2.11	1.21	2.71
Preadipocyte - visceral, donor2.CNhs11982.11357-117H7	5.71	3.12	1.56	1.56	0.52
optic nerve, donor1.CNhs13449.10277-104E7	5.71	4.28	0.00	2.86	1.43
retinoblastoma cell line:Y79.CNhs11267.10475-106I7	5.69	6.48	1.11	0.16	0.95
Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3	5.67	4.90	2.58	1.03	0.77
Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5	5.67	4.26	1.42	0.00	2.84
thyroid, fetal, donor1.CNhs11769.10060-101H6	5.66	4.45	4.04	1.62	2.22
merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7	5.65	5.80	4.20	0.43	4.06
Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5	5.63	6.63	1.33	0.66	1.33
small intestine, adult, pool1.CNhs10630.10024-101D6	5.63	3.16	2.78	2.32	1.08
Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9	5.62	3.75	3.75	4.69	0.00
mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1	5.60	4.00	0.40	1.20	0.40
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7	5.58	1.55	0.62	1.55	0.31
Adipocyte - breast, donor2.CNhs11969.11327-117E4	5.57	6.64	3.00	1.71	0.86
Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2	5.56	1.80	4.58	0.65	0.49
cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3	5.56	8.40	6.18	4.82	1.24
Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8	5.55	3.82	4.17	2.08	0.35
Fibroblast - skin normal, donor2.CNhs11914.11561-120D4	5.55	3.80	2.34	0.78	0.29
tenocyte, donor2.CNhs12640.11765-123I1	5.55	10.63	1.39	2.77	1.85
esophagus, adult, pool1.CNhs10620.10015-101C6	5.53	3.49	2.62	1.75	2.04
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2	5.52	1.00	1.51	13.56	1.00
testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8	5.51	1.56	7.35	0.28	0.18
Cardiac Myocyte, donor3.CNhs12571.11686-122I3	5.50	6.52	0.38	0.90	0.26
Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5	5.50	11.50	3.00	2.00	0.50
Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6	5.49	6.31	2.20	0.55	0.55
Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2	5.45	2.58	1.72	3.44	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5	5.45	4.70	4.62	0.08	1.07
leiomyoma cell line:10964C.CNhs11722.10569-108B2	5.43	9.23	0.00	1.09	1.09
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4	5.42	7.23	1.81	3.01	0.60
Neurons, donor1.CNhs12338.11494-119E9	5.41	10.83	1.55	0.00	0.77
mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9	5.41	7.13	0.00	4.92	0.98
Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6	5.40	4.37	3.34	1.03	1.03
paracentral gyrus, adult, pool1.CNhs10642.10035-101E8	5.40	21.41	3.24	1.22	2.36
Neutrophils, donor3.CNhs11905.11390-118C4	5.39	2.90	6.63	1.24	2.49
Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9	5.39	1.54	1.54	0.26	0.26
bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9	5.39	2.34	1.62	2.79	0.63
neuroblastoma cell line:NB-1.CNhs11284.10539-107G8	5.39	6.58	2.70	0.86	1.29
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5	5.38	6.05	2.69	1.34	0.67
endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4	5.38	2.60	1.21	0.17	0.35
Cardiac Myocyte, donor2.CNhs12350.11605-120I3	5.37	6.04	4.69	2.01	0.67
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6	5.37	7.52	0.54	1.29	1.07
signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6	5.36	4.02	3.78	2.80	1.71
amniotic membrane cells, donor2.CNhs12503.12236-129G4	5.35	2.67	2.38	2.67	1.48
bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4	5.35	2.62	2.96	1.25	0.46
Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4	5.34	4.27	3.20	0.00	1.07
gall bladder, adult.CNhs12848.10198-103E9	5.34	3.42	1.71	1.92	0.64
ovary, adult, pool1.CNhs10626.10020-101D2	5.34	3.99	2.86	0.90	1.35
cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8	5.33	7.21	4.80	5.95	1.15
occipital lobe, adult, donor1.CNhs11787.10076-102A4	5.33	12.72	1.85	0.82	2.46
Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1	5.32	2.28	5.32	7.60	0.76
Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8	5.32	4.97	2.48	0.35	1.06
hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1	5.26	3.68	1.31	0.53	1.05
Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9	5.25	6.56	0.00	0.00	1.31
adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7	5.24	3.45	3.12	4.23	3.01
chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4	5.24	0.64	4.93	5.72	0.95
mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8	5.22	7.30	3.13	4.17	0.52
Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1	5.21	5.95	2.61	0.74	0.37
Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7	5.20	12.48	3.12	1.04	0.00
Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6	5.19	7.97	2.22	2.97	0.56
hippocampus, adult, donor10252.CNhs12312.10153-102I9	5.18	15.80	9.67	0.27	3.13
Sebocyte, donor1.CNhs10847.11220-116B5	5.17	3.45	4.59	1.72	0.00
temporal lobe, adult, pool1.CNhs10637.10031-101E4	5.17	26.99	2.11	1.36	2.58
insula, adult, pool1.CNhs10646.10039-101F3	5.16	22.11	3.10	1.21	2.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8	5.15	5.15	0.69	0.69	0.69
epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8	5.14	5.40	2.70	1.74	0.44
mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2	5.14	5.14	1.40	0.93	0.23
Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5	5.10	2.02	3.27	1.06	0.48
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6	5.10	4.18	2.32	1.86	0.93
pons, adult, pool1.CNhs10640.10033-101E6	5.10	20.87	3.13	0.88	1.84
Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3	5.07	5.32	0.63	1.27	0.51
Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1	5.06	5.69	1.58	2.53	0.63
squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9	5.06	7.62	4.41	2.25	1.04
Meningeal Cells, donor1.CNhs11320.11493-119E8	5.05	3.92	4.04	0.67	0.78
testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5	5.01	0.25	1.25	0.50	0.50
glioblastoma cell line:T98G.CNhs11272.10485-107A8	5.00	8.26	1.53	1.43	0.92
Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8	4.99	3.06	0.57	1.47	1.02
Olfactory epithelial cells, donor1.CNhs13816.11933-125I7	4.99	5.62	1.04	2.91	2.08
Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3	4.98	4.27	2.85	2.49	1.78
Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3	4.98	10.58	5.60	0.93	0.00
Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3	4.97	4.47	0.50	3.98	0.50
Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6	4.97	7.80	1.42	1.06	1.06
Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3	4.96	9.46	3.00	3.61	1.05
Mallassez-derived cells, donor3.CNhs13551.11930-125I4	4.96	2.69	1.70	1.56	0.57
trachea, adult, pool1.CNhs10635.10029-101E2	4.95	2.80	4.30	3.51	1.36
Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5	4.93	7.70	5.85	2.46	0.62
Hepatocyte, donor2.CNhs12349.11603-120I1	4.91	2.95	0.98	2.95	0.00
Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2	4.86	6.48	2.43	4.05	2.43
Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8	4.85	6.47	2.43	1.82	0.61
Urothelial cells, donor0.CNhs10843.11216-116B1	4.82	2.07	0.69	3.45	0.46
CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7	4.81	1.37	2.75	4.12	0.69
frontal lobe, adult, pool1.CNhs10647.10040-101F4	4.81	19.75	3.10	1.01	2.15
Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7	4.79	4.97	2.03	0.55	0.46
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5	4.78	6.06	1.12	0.48	1.28
anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3	4.78	5.27	4.45	1.48	0.49
tenocyte, donor3.CNhs12641.11768-123I4	4.76	6.49	3.03	3.03	0.87
CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3	4.75	0.55	1.46	1.46	0.73
cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2	4.74	3.56	10.38	5.63	0.89
granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3	4.73	5.59	1.29	3.01	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4	4.73	4.73	1.09	2.18	0.55
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4	4.72	1.65	9.37	3.38	1.89
Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1	4.72	1.12	3.59	0.67	0.00
Preadipocyte - breast, donor1.CNhs11052.11467-119B9	4.71	5.46	1.24	1.24	0.99
prostate, adult, pool1.CNhs10628.10022-101D4	4.71	4.55	6.36	2.35	1.96
Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6	4.70	6.44	0.74	0.62	0.99
Mesothelial Cells, donor3.CNhs12012.11402-118D7	4.70	5.60	1.20	1.80	0.30
teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6	4.67	2.90	2.40	0.38	0.25
Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8	4.65	4.03	3.72	1.24	0.93
CD8+ T Cells, donor1.CNhs10854.11226-116C2	4.64	1.61	1.21	3.43	0.20
amygdala, adult, donor10252.CNhs12311.10151-102I7	4.64	13.36	8.44	0.98	2.25
immature langerhans cells, donor2.CNhs13480.11905-125F6	4.64	0.00	6.96	3.87	0.77
Keratinocyte - oral, donor1.CNhs10879.11251-116E9	4.63	1.76	1.85	0.74	0.56
Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4	4.63	3.37	4.63	1.69	0.42
Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3	4.62	6.04	0.71	0.36	1.07
lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4	4.62	5.82	1.37	1.37	0.68
CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2	4.61	0.97	5.82	1.94	0.49
neuroblastoma cell line:NH-12.CNhs11811.10555-107I6	4.59	2.51	5.35	0.11	0.11
Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1	4.58	4.58	4.10	2.17	0.72
cerebellum - adult, donor10196.CNhs13799.10173-103C2	4.58	10.68	16.78	1.53	0.00
small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7	4.58	6.17	5.37	0.20	0.60
leiomyoma cell line:15425.CNhs11724.10571-108B4	4.57	7.18	0.65	1.31	0.33
medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1	4.57	1.11	0.97	0.28	1.11
nucleus accumbens, adult, pool1.CNhs10644.10037-101F1	4.56	21.07	4.50	1.16	2.44
Fibroblast - Gingival, donor2.CNhs11961.11318-117D4	4.54	2.95	2.70	0.61	1.11
Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1	4.54	7.24	2.70	0.86	1.10
argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4	4.53	3.78	3.53	0.00	0.50
Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6	4.52	3.26	2.13	0.50	1.13
mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3	4.52	7.18	1.06	1.06	0.53
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2	4.51	0.84	8.18	4.05	1.68
Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8	4.48	6.62	3.84	0.64	0.64
epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2	4.47	9.12	1.55	1.38	1.20
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3	4.43	1.89	8.21	3.61	1.81
medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8	4.43	11.52	2.66	0.89	2.66
schwannoma cell line:HS-PSS.CNhs11183.10442-106F1	4.43	3.24	1.53	0.09	0.68
parotid gland, adult.CNhs12849.10199-103F1	4.39	2.19	2.19	1.64	1.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6	4.38	8.03	1.46	5.11	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1	4.38	8.36	1.19	2.39	0.00
teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7	4.37	2.29	2.84	0.00	0.22
Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1	4.35	10.44	3.48	0.00	0.00
colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6	4.33	1.73	1.51	0.00	0.87
mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1	4.33	4.93	1.19	2.39	0.75
heart - tricuspid valve, adult.CNhs12857.10207-103F9	4.31	1.44	10.77	2.87	1.44
heart, fetal, pool1.CNhs10653.10046-101G1	4.30	3.43	6.52	0.00	1.81
salivary gland, adult, pool1.CNhs11677.10093-102C3	4.30	4.73	6.45	3.87	1.29
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5	4.29	0.90	6.77	0.68	0.45
mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8	4.29	8.36	0.64	1.50	0.43
normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2	4.29	7.66	0.92	1.84	0.31
papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3	4.29	3.25	1.33	1.63	0.44
Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4	4.28	1.43	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1	4.26	8.52	3.73	2.66	0.53
adipose tissue, adult, pool1.CNhs10615.10010-101C1	4.25	2.49	6.30	1.76	2.05
spleen, fetal, pool1.CNhs10651.10044-101F8	4.25	2.38	8.51	3.48	1.61
spinal cord, fetal, donor1.CNhs11764.10056-101H2	4.23	11.41	2.11	0.00	2.54
CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4	4.22	0.77	1.92	2.30	0.77
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8	4.22	0.00	2.11	8.43	6.33
Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1	4.20	1.52	1.96	0.63	0.54
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6	4.20	3.40	1.40	5.80	1.20
acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8	4.19	2.39	4.39	0.40	0.80
Basophils, donor3.CNhs12575.12243-129H2	4.18	2.17	0.93	2.17	0.93
Pancreatic stromal cells, donor1.CNhs10877.11249-116E7	4.17	4.26	1.91	2.09	0.78
Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1	4.13	7.17	0.98	2.36	0.59
submaxillary gland, adult.CNhs12852.10202-103F4	4.13	1.38	6.88	1.38	0.46
CD14+ Monocytes, donor3.CNhs11997.11381-118B4	4.12	0.87	0.87	4.77	1.30
large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2	4.12	4.30	3.05	0.54	0.54
gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2	4.11	7.43	3.91	1.37	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6	4.10	1.76	5.08	0.20	0.98
leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5	4.10	2.13	3.69	2.38	0.33
lung, fetal, donor1.CNhs11680.10068-101I5	4.09	1.26	7.23	0.47	1.26
Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9	4.07	1.45	2.33	2.03	0.58
uterus, fetal, donor1.CNhs11763.10055-101H1	4.07	2.44	3.26	0.00	2.44
Osteoblast, donor3.CNhs12036.11426-118G4	4.06	3.32	3.32	1.11	1.11
acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9	4.06	1.89	7.30	2.70	1.35
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6	4.04	3.79	2.02	0.50	1.26
cervical cancer cell line:ME-180.CNhs11289.10553-107I4	4.04	1.39	0.98	0.98	0.42
cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3	4.03	3.38	3.92	0.87	0.54
medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3	4.03	11.84	2.44	0.98	1.22
Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7	4.02	3.35	2.68	3.35	1.00
mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1	4.01	1.69	1.27	2.32	0.42
Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8	3.99	7.45	2.39	2.13	0.53
temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9	3.98	4.90	2.14	0.31	3.67
CD34+ Progenitors, donor1.CNhs13227.11545-120B6	3.97	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3	3.97	7.68	9.40	1.32	0.79
Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7	3.95	9.65	2.19	2.63	0.00
Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7	3.93	5.65	1.72	2.46	1.23
CD4+ T Cells, donor1.CNhs10853.11225-116C1	3.93	0.59	1.38	2.16	0.59
Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3	3.92	5.49	5.49	2.35	0.00
tongue, adult.CNhs12853.10203-103F5	3.92	0.44	3.27	1.31	0.65
Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2	3.91	3.26	1.63	1.30	0.33
parietal lobe - adult, donor10196.CNhs13797.10171-103B9	3.91	4.69	2.34	2.34	3.12
Neural stem cells, donor2.CNhs11384.11352-117H2	3.90	7.81	1.30	0.00	2.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5	3.90	6.82	1.71	3.41	0.49
Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1	3.89	1.51	1.08	1.51	0.22
mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3	3.88	2.22	1.66	0.55	1.11
myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7	3.84	1.71	2.99	0.00	1.39
neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4	3.84	4.86	4.22	0.13	0.77
CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1	3.82	1.47	2.94	1.76	0.59
Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9	3.81	7.21	1.91	1.27	1.06
aorta, adult, pool1.CNhs11760.10052-101G7	3.79	2.39	3.79	1.00	1.20
heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5	3.79	5.79	2.20	2.40	1.00
myeloma cell line:PCM6.CNhs11258.10474-106I6	3.79	3.96	3.62	4.31	0.17
Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1	3.78	1.79	6.96	0.60	0.40
Fibroblast - Dermal, donor3.CNhs12028.11418-118F5	3.74	3.74	1.05	2.39	0.45
caudate nucleus, adult, donor10252.CNhs12321.10164-103B2	3.74	19.17	8.44	0.96	1.69
cerebral meninges, adult.CNhs12840.10188-103D8	3.73	10.75	2.19	0.22	1.10
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6	3.73	0.78	9.02	0.59	0.59
mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8	3.73	5.13	0.78	0.62	0.78
small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1	3.73	1.58	3.16	0.23	0.34
spinal cord - adult, donor10196.CNhs13807.10181-103D1	3.73	5.50	3.73	0.79	2.94
Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2	3.72	4.87	2.86	0.00	0.86
Fibroblast - Gingival, donor3.CNhs12006.11394-118C8	3.72	7.75	2.38	0.00	0.83
colon, adult, pool1.CNhs10619.10014-101C5	3.72	1.77	3.80	1.42	0.71
CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1	3.67	0.92	1.22	2.14	0.31
colon, fetal, donor1.CNhs11780.10070-101I7	3.67	3.06	3.06	2.44	1.22
rectum, fetal, donor1.CNhs11777.10067-101I4	3.65	4.57	7.31	2.74	1.83
tonsil, adult, pool1.CNhs10654.10047-101G2	3.64	2.56	5.32	3.17	0.81
cervix, adult, pool1.CNhs10618.10013-101C4	3.62	3.54	3.46	0.77	0.92
locus coeruleus - adult, donor10196.CNhs13808.10182-103D2	3.62	10.86	4.27	0.52	2.71
mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7	3.61	6.61	1.20	1.05	0.45
Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9	3.60	3.77	1.89	0.17	0.17
globus pallidus - adult, donor10196.CNhs13801.10175-103C4	3.60	5.40	6.00	1.20	1.80
mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4	3.60	9.09	0.38	1.52	0.19
CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4	3.58	0.56	4.71	2.82	1.13
left atrium, adult, donor1.CNhs11790.10079-102A7	3.57	3.57	0.71	0.71	1.43
throat, fetal, donor1.CNhs11770.10061-101H7	3.57	2.86	4.29	0.24	1.43
anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5	3.56	7.24	2.67	1.56	0.78
mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4	3.56	4.45	2.67	1.78	0.89
Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9	3.54	5.23	4.22	0.34	0.34
glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4	3.54	3.06	1.41	0.47	0.94
Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6	3.53	0.92	3.22	1.07	0.15
lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3	3.52	11.98	16.21	1.41	0.70
small intestine, fetal, donor1.CNhs11773.10064-101I1	3.50	0.87	3.50	2.62	1.09
CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6	3.49	0.46	4.65	4.18	0.23
Fibroblast - Gingival, donor1.CNhs10866.11237-116D4	3.47	4.08	2.45	0.61	0.20
leiomyoma cell line:15242A.CNhs11723.10570-108B3	3.46	6.91	2.59	1.73	0.86
Basophils, donor2.CNhs12563.12242-129H1	3.45	0.38	1.15	1.92	0.38
Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2	3.44	4.45	1.15	0.57	0.57
Mast cell, donor1.CNhs12566.11563-120D6	3.43	2.29	4.67	2.82	0.44
epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3	3.43	2.74	1.18	0.59	0.29
Fibroblast - Dermal, donor2.CNhs11379.11346-117G5	3.42	2.85	12.55	1.14	0.57
basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9	3.42	4.98	0.62	6.53	0.31
Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8	3.41	4.80	2.87	1.32	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9	3.41	0.43	2.13	2.98	0.43
liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8	3.41	4.77	2.56	2.73	0.34
Fibroblast - Dermal, donor5.CNhs12055.11454-119A5	3.40	0.65	3.56	0.65	0.65
Lens Epithelial Cells, donor3.CNhs12572.11690-122I7	3.40	7.28	1.06	1.64	0.47
acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9	3.39	4.02	7.62	1.48	0.64
CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7	3.38	0.00	1.69	3.38	0.63
Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6	3.38	0.85	1.69	0.00	0.85
Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8	3.37	7.66	0.31	2.45	0.00
Preadipocyte - visceral, donor3.CNhs12039.11429-118G7	3.37	4.42	0.35	1.39	0.35
CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5	3.36	0.67	7.61	2.24	1.34
CD34+ Progenitors, donor2.CNhs12205.11625-122B5	3.36	0.00	2.80	2.80	1.12
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7	3.36	1.34	9.90	0.84	0.67
thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9	3.36	5.61	4.37	1.12	0.22
mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1	3.35	4.94	1.27	0.96	0.64
tenocyte, donor1.CNhs12639.11763-123H8	3.35	6.32	1.49	0.74	0.00
Myoblast, donor1.CNhs10870.11241-116D8	3.33	4.78	1.59	1.74	0.43
Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2	3.32	5.64	2.52	0.30	0.71
transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6	3.31	1.28	2.03	1.39	0.32
CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7	3.30	0.00	5.28	1.32	2.31
Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1	3.30	3.65	2.59	0.24	0.71
Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8	3.29	4.12	0.82	0.82	0.82
Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8	3.29	1.65	8.23	2.47	0.41
acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1	3.29	0.47	3.60	0.78	0.16
Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6	3.28	5.73	2.46	1.09	0.96
Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5	3.27	2.59	3.27	1.24	0.68
CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7	3.26	0.98	0.33	1.63	0.98
Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4	3.25	5.18	2.20	0.18	0.44
Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6	3.24	3.24	1.23	2.00	0.15
Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4	3.24	0.00	14.27	3.89	0.65
Fibroblast - Dermal, donor6.CNhs12059.11458-119A9	3.23	1.69	2.39	0.14	0.84
Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9	3.22	5.83	5.22	0.77	1.53
Sertoli Cells, donor1.CNhs10851.11255-116F4	3.21	6.43	1.61	3.21	1.61
lung, adult, pool1.CNhs10625.10019-101D1	3.20	1.71	2.78	1.92	0.75
malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7	3.19	0.64	5.11	3.83	0.64
pituitary gland, adult, donor10252.CNhs12229.10162-103A9	3.19	4.10	11.84	0.23	1.14
schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1	3.19	3.31	0.95	0.24	0.83
hippocampus - adult, donor10196.CNhs13795.10169-103B7	3.18	10.34	4.77	0.80	1.59
large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5	3.17	4.22	1.69	1.16	0.32
CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6	3.15	0.90	6.07	2.47	0.45
CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8	3.14	0.00	0.86	1.71	1.43
embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3	3.14	4.40	4.40	2.51	0.63
Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9	3.12	4.16	3.50	0.47	0.57
Fibroblast - Dermal, donor1.CNhs12499.11269-116G9	3.12	4.06	1.56	2.50	0.00
oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5	3.12	1.83	2.20	1.65	0.37
Prostate Stromal Cells, donor1.CNhs10883.11254-116F3	3.10	4.13	2.99	1.61	0.80
spleen, adult, pool1.CNhs10631.10025-101D7	3.10	1.32	6.01	4.14	1.32
Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2	3.08	2.16	2.00	0.62	0.77
heart - mitral valve, adult.CNhs12855.10205-103F7	3.07	3.07	6.98	1.95	1.40
meningioma cell line:HKBMM.CNhs11945.10691-109F7	3.06	2.59	2.59	0.71	0.24
Fibroblast - Dermal, donor4.CNhs12052.11450-119A1	3.05	1.76	3.17	0.23	0.35
diencephalon, adult.CNhs12610.10193-103E4	3.05	8.43	1.87	2.58	1.17
leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1	3.05	7.37	2.29	0.51	0.51
CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6	3.03	0.79	1.68	1.46	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9	3.03	6.73	1.01	2.02	0.34
vein, adult.CNhs12844.10191-103E2	3.02	1.01	4.03	5.03	0.81
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8	3.01	1.76	2.51	1.76	0.50
CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5	3.00	0.27	5.73	2.46	2.18
acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6	3.00	3.00	3.33	0.67	0.33
synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9	3.00	4.26	2.37	0.32	0.95
amygdala - adult, donor10196.CNhs13793.10167-103B5	2.98	8.95	1.99	0.99	0.99
penis, adult.CNhs12850.10200-103F2	2.98	1.49	5.95	2.48	0.99
epididymis, adult.CNhs12847.10197-103E8	2.97	2.10	3.15	1.05	1.92
small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5	2.97	0.99	1.21	0.00	0.55
Hepatocyte, donor3.CNhs12626.11684-122I1	2.95	2.36	4.73	1.18	1.18
mature adipocyte, donor4.CNhs12562.12234-129G2	2.95	0.00	1.31	1.31	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5	2.95	5.74	2.95	2.02	0.47
pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3	2.94	2.68	1.15	4.09	0.89
Prostate Stromal Cells, donor2.CNhs11973.11332-117E9	2.91	4.55	2.73	5.46	1.09
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4	2.91	2.68	2.68	1.79	0.89
skin, fetal, donor1.CNhs11774.10065-101I2	2.91	1.46	2.43	0.49	0.97
Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2	2.90	2.39	3.92	0.77	0.51
Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1	2.89	7.52	6.37	0.58	0.00
Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5	2.88	2.88	4.75	0.50	0.38
Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6	2.88	4.24	2.71	0.85	1.02
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5	2.87	3.82	2.87	0.00	0.00
thymus, fetal, pool1.CNhs10650.10043-101F7	2.86	1.80	12.35	1.49	0.81
CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8	2.85	1.05	1.35	1.50	1.05
Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8	2.84	2.84	3.27	2.84	0.43
dura mater, adult, donor1.CNhs10648.10041-101F5	2.84	3.60	0.82	1.58	0.70
uterus, adult, pool1.CNhs11676.10100-102D1	2.81	2.69	7.70	0.73	0.49
Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7	2.79	1.86	3.99	5.98	0.66
Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7	2.79	3.22	2.69	0.54	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1	2.78	0.25	1.01	0.25	0.51
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6	2.77	3.70	1.92	0.28	1.07
lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7	2.77	2.37	0.59	4.15	0.40
throat, adult.CNhs12858.10209-103G2	2.77	2.13	4.69	1.28	0.64
CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5	2.76	0.69	2.07	2.41	0.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9	2.76	0.83	1.11	0.83	1.11
neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7	2.76	3.61	3.83	0.00	1.28
olfactory region, adult.CNhs12611.10195-103E6	2.75	13.73	2.10	0.65	0.97
signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4	2.75	2.94	2.55	0.49	0.29
CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7	2.73	0.55	5.46	4.92	1.64
neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6	2.73	3.84	2.97	0.87	0.74
parietal lobe, fetal, donor1.CNhs11782.10072-101I9	2.73	2.19	0.00	1.09	1.64
spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8	2.72	6.12	0.34	1.53	0.51
acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6	2.70	1.72	0.49	1.96	0.98
Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3	2.69	6.08	2.97	0.85	0.42
Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3	2.68	5.26	1.75	0.72	0.52
heart, adult, pool1.CNhs10621.10016-101C7	2.68	2.45	2.90	0.67	1.12
Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6	2.66	6.92	1.07	1.42	0.18
CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1	2.65	0.38	5.29	1.89	1.51
Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8	2.63	6.58	2.63	1.76	0.44
Reticulocytes, biol_rep1.CNhs13552.11931-125I5	2.63	3.07	6.58	7.89	0.88
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3	2.60	1.73	0.58	0.14	1.15
CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7	2.56	0.00	1.28	2.05	1.02
Neurons, donor3.CNhs13815.11655-122E8	2.55	4.47	1.91	0.64	0.00
Hepatocyte, donor1.CNhs12340.11523-119I2	2.54	1.27	2.54	1.27	0.00
Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1	2.54	2.03	15.73	3.04	1.52
plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3	2.54	2.42	2.54	2.65	0.46
Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8	2.53	0.00	7.60	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5	2.52	3.32	1.35	0.81	0.54
acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7	2.51	1.95	10.30	0.84	1.11
mesothelioma cell line:Mero-41.CNhs13067.10851-111F5	2.49	2.72	2.27	4.31	0.00
thalamus - adult, donor10196.CNhs13794.10168-103B6	2.49	9.12	6.63	1.66	0.83
Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1	2.48	2.07	3.03	0.96	0.55
lymph node, adult, donor1.CNhs11788.10077-102A5	2.48	0.50	0.00	4.47	1.49
CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9	2.47	1.16	5.09	1.74	1.45
Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7	2.47	4.06	2.90	0.58	0.00
bladder, adult, pool1.CNhs10616.10011-101C2	2.47	2.47	3.95	0.99	0.59
Cardiac Myocyte, donor1.CNhs12341.11525-119I4	2.44	4.88	0.00	0.00	0.00
Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9	2.44	4.21	3.33	0.44	1.11
duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8	2.42	3.63	1.21	1.21	1.21
diaphragm, fetal, donor1.CNhs11779.10069-101I6	2.41	0.80	4.01	0.00	0.80
pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4	2.40	4.63	1.20	1.20	0.34
tongue, fetal, donor1.CNhs11768.10059-101H5	2.40	3.08	1.71	1.03	0.68
CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8	2.39	0.40	3.19	1.99	0.20
Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4	2.38	0.24	1.19	0.95	0.48
acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3	2.37	0.51	2.37	0.34	0.68
Reticulocytes, biol_rep2.CNhs13553.11932-125I6	2.35	0.52	7.06	7.84	0.78
small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6	2.35	2.35	1.88	0.00	0.47
umbilical cord, fetal, donor1.CNhs11765.10057-101H3	2.35	7.04	7.04	0.00	0.00
b cell line:RPMI1788.CNhs10744.10427-106D4	2.34	0.62	2.09	1.11	0.12
Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9	2.30	12.28	3.84	1.28	0.77
acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6	2.30	1.15	3.45	2.87	0.38
splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1	2.30	1.90	5.10	2.10	0.70
Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4	2.29	1.14	1.72	4.00	0.57
Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3	2.28	1.71	14.24	3.99	1.71
CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5	2.27	0.65	4.53	6.48	0.97
acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5	2.27	1.62	0.97	1.62	1.30
Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3	2.26	1.92	4.53	5.92	1.22
Neutrophils, donor1.CNhs10862.11233-116C9	2.25	3.75	2.25	2.25	3.00
giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1	2.24	2.73	1.86	0.37	0.50
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5	2.23	2.23	1.67	0.74	0.93
CD14+ Monocytes, donor1.CNhs10852.11224-116B9	2.22	0.55	1.11	1.11	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3	2.21	0.37	4.42	2.21	0.37
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9	2.17	1.00	1.33	0.17	0.50
Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5	2.16	1.62	14.58	1.62	1.08
ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6	2.15	7.04	4.70	1.57	0.20
Preadipocyte - visceral, donor1.CNhs11082.11280-116I2	2.14	4.27	0.90	1.23	0.25
Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6	2.14	6.78	3.21	1.07	0.36
mature adipocyte, donor3.CNhs12560.12233-129G1	2.14	1.84	2.76	2.14	0.61
squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4	2.14	1.79	2.32	1.07	0.18
Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2	2.13	0.96	1.49	2.13	0.96
clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6	2.12	1.63	2.12	0.65	1.14
CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4	2.10	0.63	1.89	3.77	1.68
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9	2.09	0.52	4.17	1.04	1.56
CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7	2.09	0.00	0.00	1.05	0.00
Mast cell, donor4.CNhs12592.11567-120E1	2.02	1.39	2.78	4.80	1.51
giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1	2.02	0.72	8.64	0.14	0.43
CD14+ Monocytes, donor2.CNhs11954.11305-117B9	2.01	0.60	0.40	2.21	1.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3	2.01	1.78	3.57	2.45	0.78
Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2	2.00	2.00	3.43	0.43	0.43
melanoma cell line:G-361.CNhs11254.10465-106H6	2.00	3.71	3.43	0.29	0.29
CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6	1.99	0.22	1.55	0.89	0.89
embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1	1.99	5.98	1.33	2.66	0.00
endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2	1.99	2.56	1.71	0.00	0.28
left ventricle, adult, donor1.CNhs11789.10078-102A6	1.99	0.66	0.66	0.66	0.00
CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4	1.98	1.98	3.97	1.32	2.64
Myoblast, donor3.CNhs11908.11398-118D3	1.97	4.83	2.51	1.61	0.72
rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1	1.96	3.08	4.48	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8	1.95	0.00	1.95	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3	1.92	0.00	3.20	2.56	0.64
CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1	1.91	1.28	2.34	2.55	1.49
Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5	1.91	6.10	1.53	2.48	0.38
CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4	1.90	0.00	2.22	2.22	0.00
CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9	1.90	1.90	1.90	0.95	0.00
clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8	1.90	1.90	1.90	3.38	0.84
CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1	1.89	0.95	5.68	0.24	1.18
somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7	1.89	10.13	4.01	0.24	0.24
maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9	1.88	2.36	2.67	0.63	0.79
thymus, adult, pool1.CNhs10633.10027-101D9	1.87	2.39	6.20	2.65	1.29
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3	1.84	0.92	2.77	0.92	0.92
gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1	1.84	4.01	2.24	0.88	0.32
Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3	1.78	2.08	3.12	9.07	0.89
CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2	1.76	1.76	8.80	3.52	0.00
mature adipocyte, donor2.CNhs12559.12232-129F9	1.75	1.75	4.01	2.01	0.25
CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3	1.74	0.00	2.03	3.77	0.29
Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6	1.73	5.19	2.88	0.58	1.73
Mast cell, donor3.CNhs12593.11566-120D9	1.73	1.15	1.01	3.17	0.43
Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8	1.72	0.74	4.92	5.91	1.23
Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7	1.72	5.58	2.00	0.43	0.43
medulla oblongata - adult, donor10196.CNhs13800.10174-103C3	1.72	6.31	4.59	1.15	0.57
smooth muscle, adult, pool1.CNhs11755.10048-101G3	1.72	3.43	2.21	1.47	0.00
Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8	1.71	4.28	2.14	1.28	0.43
Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7	1.67	1.91	8.58	2.14	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9	1.66	6.22	1.66	0.83	0.41
Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3	1.65	8.23	2.06	0.00	0.41
CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7	1.64	0.00	4.52	4.11	0.41
mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2	1.63	2.03	2.03	1.22	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9	1.62	0.27	0.81	0.27	0.81
acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5	1.61	0.00	6.46	0.20	0.40
CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2	1.60	0.00	1.93	3.21	0.32
acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9	1.60	1.37	2.28	0.46	0.46
non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1	1.60	7.21	3.20	0.00	1.60
sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2	1.60	8.82	2.41	0.00	0.80
xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5	1.60	1.92	2.89	2.56	1.28
Chondrocyte - re diff, donor2.CNhs11373.11339-117F7	1.59	2.39	7.16	0.80	0.80
Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6	1.59	1.59	7.14	0.79	1.59
neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9	1.59	4.45	0.00	2.86	0.32
gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9	1.58	1.15	0.86	0.43	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7	1.58	1.66	2.29	0.08	0.24
immature langerhans cells, donor1.CNhs13537.11904-125F5	1.57	0.00	3.60	3.60	0.45
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3	1.56	1.30	3.25	2.47	0.91
pancreas, adult, donor1.CNhs11756.10049-101G4	1.56	1.56	9.38	1.56	0.00
CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2	1.54	0.77	2.94	1.66	0.26
gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3	1.54	3.43	3.26	0.17	0.69
biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7	1.53	0.51	3.07	0.51	1.02
Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5	1.52	1.18	1.35	0.17	0.51
Mast cell - stimulated, donor1.CNhs11073.11487-119E2	1.48	0.99	51.24	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9	1.47	1.18	2.65	0.88	0.59
NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3	1.46	3.47	1.12	0.56	0.45
carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8	1.46	1.17	0.29	0.00	0.58
stomach, fetal, donor1.CNhs11771.10062-101H8	1.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4	1.45	0.48	2.25	0.16	0.80
hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4	1.44	4.32	2.16	1.44	0.36
skeletal muscle, adult, pool1.CNhs10629.10023-101D5	1.44	1.03	3.70	0.62	0.41
CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8	1.42	0.24	2.60	1.66	0.47
occipital cortex - adult, donor10196.CNhs13798.10172-103C1	1.42	14.17	1.42	0.00	2.83
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8	1.41	1.79	3.33	1.67	0.64
acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1	1.41	2.82	7.05	7.05	0.00
putamen, adult, donor10196.CNhs12324.10176-103C5	1.41	18.85	3.77	0.16	2.04
Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9	1.39	4.16	3.32	0.00	0.28
Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4	1.39	8.36	4.18	1.39	2.79
CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7	1.35	0.00	5.42	2.71	0.00
mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7	1.35	6.93	0.77	3.66	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1	1.33	0.66	1.99	3.82	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3	1.30	0.97	4.87	5.19	1.62
CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6	1.29	0.00	3.87	2.58	0.00
diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1	1.28	1.09	1.46	1.64	0.00
CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8	1.27	0.00	4.14	0.96	0.32
Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6	1.26	4.14	1.80	0.90	0.36
CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5	1.25	0.00	1.87	4.98	0.00
CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5	1.25	1.25	6.25	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8	1.24	0.31	6.81	0.93	0.93
Mast cell, donor2.CNhs12594.11565-120D8	1.24	0.83	2.49	4.35	0.41
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5	1.22	6.08	2.43	14.59	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1	1.22	1.58	0.97	1.46	1.22
CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2	1.21	0.00	0.61	2.42	2.42
pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3	1.21	5.04	2.42	2.22	0.00
pituitary gland - adult, donor10196.CNhs13805.10180-103C9	1.21	4.25	3.64	0.61	1.21
Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7	1.19	11.88	3.56	2.38	0.00
embryonic pancreas cell line:2C6.CNhs11814.10603-108E9	1.19	3.58	2.39	0.00	0.00
migratory langerhans cells, donor1.CNhs13535.11901-125F2	1.17	0.39	11.89	3.90	0.97
CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6	1.15	0.29	2.30	2.01	0.58
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5	1.15	0.99	2.96	1.97	0.16
myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6	1.14	8.51	2.27	2.84	0.00
CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2	1.13	0.96	2.09	1.29	0.48
neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8	1.12	5.03	3.91	1.12	2.23
Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8	1.11	0.37	2.23	2.23	1.49
appendix, adult.CNhs12842.10189-103D9	1.11	1.38	9.95	3.59	0.28
mature adipocyte, donor1.CNhs12558.12231-129F8	1.09	1.63	1.63	2.72	0.54
pineal gland - adult, donor10196.CNhs13804.10179-103C8	1.07	9.64	4.29	0.00	1.07
migratory langerhans cells, donor2.CNhs13536.11902-125F3	1.06	0.80	4.78	9.43	0.80
CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9	1.03	1.03	6.18	3.09	1.03
Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7	1.03	0.62	0.41	1.45	0.41
bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7	1.02	1.53	0.76	0.25	0.51
pineal gland, adult, donor10252.CNhs12228.10160-103A7	1.01	8.41	16.48	0.67	2.69
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2	1.00	1.00	3.01	0.17	0.84
migratory langerhans cells, donor3.CNhs13547.11903-125F4	0.98	0.16	3.11	4.58	0.65
CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9	0.95	0.00	4.77	0.00	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5	0.95	0.95	0.95	0.95	0.95
CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6	0.90	1.66	5.27	1.20	0.90
CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3	0.89	0.89	1.78	1.78	2.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2	0.89	0.15	0.74	0.59	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1	0.87	0.43	4.34	1.30	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8	0.85	0.43	2.56	0.43	0.43
CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6	0.82	0.00	3.28	1.64	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4	0.80	0.54	0.00	0.27	0.80
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2	0.79	0.79	1.05	1.58	0.79
Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8	0.79	2.38	0.79	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9	0.78	0.78	2.35	0.47	0.31
Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2	0.76	0.76	9.18	1.53	1.53
Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8	0.70	2.11	4.21	13.81	0.47
heart - pulmonic valve, adult.CNhs12856.10206-103F8	0.69	1.60	8.25	1.15	0.23
osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6	0.69	6.21	1.38	0.69	0.00
CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4	0.65	1.95	2.60	0.65	0.65
CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4	0.57	0.57	4.54	3.40	1.13
CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8	0.57	0.57	5.17	2.30	1.72
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1	0.45	1.36	3.74	0.68	0.57
CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5	0.40	0.00	3.60	2.80	1.20
chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4	0.38	0.76	2.85	2.09	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9	0.29	0.87	3.19	1.45	0.29
Adipocyte - breast, donor1.CNhs11051.11376-118A8	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1.CNhs12342.11529-119I8	0.00	1.44	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2	0.00	0.00	2.51	2.51	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8	0.00	2.46	4.92	4.92	0.00
blood, adult, pool1.CNhs11761.10053-101G8	0.00	0.00	4.79	2.39	0.00
bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2	0.00	6.67	4.45	3.33	0.00
granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7	0.00	2.55	5.11	0.00	1.28
hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3	0.00	1.16	5.82	0.00	0.00
skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3	0.00	0.65	1.94	0.00	0.00
tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1	0.00	3.86	1.93	1.93	0.00

Showing 1 to 889 of 889 entries

0

10

20

30

40

50

60

p1@GPR137
p2@GPR137
p3@GPR137
p4@GPR137
p5@GPR137

• Click each plot point to find sample in table

ENCODE TF ChIP-seq peak enrichment analysis Analyst: Erik Arner <br>Summary: For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><br><br>link to source dataset.<br>data

---

No analysis results for this cluster

Details<b>Summary:</b>It includes sequences from the international sequence collaboration, Swiss-Prot, and RefSeq. The RefSeq subset of this file is also available as gene2refseq.<br><br>links to source dataset.<br>human <br>mouse

---

GeneID:	56834
LocusTag:	-
chromosome:	11
map location:	11cen-q22.3
type of gene:	protein-coding
Symbol from nomenclature authority:	GPR137
Full name from nomenclature authority:	G protein-coupled receptor 137
Nomenclature status:	O
Other designations:	integral membrane protein GPR137, transmembrane 7 superfamily member 1-like 1 protein, integral membrane protein GPR137;;transmembrane 7 superfamily member 1-like 1 protein
Modification date:	18.11.2011